Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C J Langer

Showing results (1-10 of 49) with videos related to

Pageof 5
Sort By:
Oncology (Williston Park, N.Y.)|August 11, 2001
The emerging world role of irinotecan in lung cancerC J Langer
Oncology (Williston Park, N.Y.)|February 28, 2001
Treatment of non-small-cell lung cancer in North America: the emerging role of irinotecanC J Langer
Drugs|March 11, 2000
The role of tegafur/uracil in pulmonary malignancyC J Langer
Seminars in Oncology|November 24, 1999
Induction or neoadjuvant therapy in resectable non-small cell lung cancerC J Langer
Current Oncology Reports|December 21, 2000
The role of new agents in advanced non-small-cell lung carcinomaC J Langer
Cancer Treatment and Research|February 28, 2001
Staging and prognosis in lung cancer: making the complex accessibleC J Langer
Seminars in Radiation Oncology|April 21, 1999
Concurrent chemoradiation using paclitaxel and carboplatin in locally advanced non-small cell lung cancerC J Langer
Investigational New Drugs|June 1, 2000
Advanced non-small cell lung carcinoma: the emerging role of docetaxelC J Langer
Lung Cancer (Amsterdam, Netherlands)|October 27, 2001
The role of UFT and the combination of UFT/leucovorin in non-small cell lung cancerC J Langer
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 3, 2001
Does salvage therapy influence outcome?C J Langer
Pageof 5

Showing results (1-10 of 49) with videos related to

Sort By:
Pageof 5
Oncology (Williston Park, N.Y.)|August 11, 2001
The emerging world role of irinotecan in lung cancerC J Langer
Oncology (Williston Park, N.Y.)|February 28, 2001
Treatment of non-small-cell lung cancer in North America: the emerging role of irinotecanC J Langer
Drugs|March 11, 2000
The role of tegafur/uracil in pulmonary malignancyC J Langer
Seminars in Oncology|November 24, 1999
Induction or neoadjuvant therapy in resectable non-small cell lung cancerC J Langer
Current Oncology Reports|December 21, 2000
The role of new agents in advanced non-small-cell lung carcinomaC J Langer
Cancer Treatment and Research|February 28, 2001
Staging and prognosis in lung cancer: making the complex accessibleC J Langer
Seminars in Radiation Oncology|April 21, 1999
Concurrent chemoradiation using paclitaxel and carboplatin in locally advanced non-small cell lung cancerC J Langer
Investigational New Drugs|June 1, 2000
Advanced non-small cell lung carcinoma: the emerging role of docetaxelC J Langer
Lung Cancer (Amsterdam, Netherlands)|October 27, 2001
The role of UFT and the combination of UFT/leucovorin in non-small cell lung cancerC J Langer
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 3, 2001
Does salvage therapy influence outcome?C J Langer
Pageof 5